Venrock Adviser, LLC

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
34
Total value ($000)
$2,058,215
Net value change ($000)
-1,239,837 (-37.6%)
New positions
7
Sold out positions
6
Turnover %
77.1%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
KORSANA BIOSCIENCES INC 145,587 NEW
DAMORA THERAPEUTICS INC 76,685 NEW
ADARX PHARMACEUTICALS INC 32,418 NEW
ACHV 26,548 147.8%
ARVN 15,103 NEW
ENTXW 14,859 NEW
ANL 14,458 39.1%
XFOR 13,135 145.4%
SVRA 10,139 11.2%
VRDN 7,233 12.1%
Top Reduces (Value $000, Stocks/ETFs)
APGE -1,127,318 -100.0%
GLTO -93,730 -100.0%
ORKA -49,283 -12.5%
SYRE -43,769 -16.5%
DNTH -42,647 -37.1%
ERAS -33,260 -10.1%
ELVN -26,711 -100.0%
JBIO -26,310 -36.8%
HELP -25,459 -100.0%
OCUL -22,246 -21.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type